Acute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.

Clinical transplants

Volumn , Issue , 2009, Pages 471-474

  Stuckey, Linda J ^a   Kamoun, Malek ^b   Wadhwa, Anish ^b   Samaniego, Millie ^b   Bartos, Cathy ^b   Berry, Jennifer ^b   Mahidhara, Raja ^b   Chang, Andrew C ^b   Chan, Kevin M ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA D ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ARTICLE; BLOOD; CASE REPORT; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; MIDDLE AGED;

BORONIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MIDDLE AGED; PROTEASE INHIBITORS; PYRAZINES;

EID: 77954566105     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)